Company Overview
Abaco Capital Plc is listed at the official companies registry as Active Public Limited Company. The company was incorporated on Wednesday 07 October 2009, so this is a well established company. Abaco Capital Plc has been in business for 14 years and 7 months. The accounts status is group and the accounts are next due on Sunday 30 June 2019.
Registered Address

2 Royal College Street, London, NW1 0NH
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameABACO CAPITAL PLC
Company Number07036758
Registered Office Address2 Royal College Street
 NW1 0NH
Company CategoryPublic Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date07/10/2009
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/06/2019
Accounts Last Made Up Date31/12/2017
Accounts Account CategoryGROUP
Returns Next Due Date04/11/2016
Returns Last Made Up Date07/10/2015
Previous Company NameChanged Date
OXFORD PHARMASCIENCE GROUP PLC20 Dec 2017
OXFORD NUTRASCIENCE GROUP PLC19 May 2011
PREBIOSYS PLC27 Jan 2010
Directors & Members
Show Resigned
John Goddard - Director
(British, 73 years old, born July 1951)
Company Director - Appointed 06 March 2014
 Active
Christopher Hill - Director
(British, 44 years old, born March 1980)
Chartered Accountant - Appointed 17 October 2013
 Active
David Norwood - Director
(British, 56 years old, born October 1968)
Director - Appointed 12 April 2011
 Active
Secretaries
Show Resigned
Christopher Hill - Secretary
Appointed 14 July 2010
 Active
Other Company Directorships
John Goddard
No companies found
Christopher Hill
OXFORD NUTRA LIMITED
OXFORD PHARMASCIENCE LIMITED
QUORAM LIMITED
David Norwood
4D PHARMA PLC
GENOMICS PLC
HVIVO PLC
HVIVO SERVICES LIMITED
OXFORD SCIENCES INNOVATION PLC
Balance Sheet Unlock full report
Accounts Date 31-Dec-2017 31-Dec-2014 31-Dec-2013
Balance Sheet
Fixed Assets 48,000 48,000 56,000
Current Assets 7,564,000 7,564,000 10,214,000
Creditors Due Within One Year 292,000 292,000 370,000
Working Cap 7,272,000 7,272,000 9,844,000
Total Assets Less Current Liabilities 7,320,000 7,320,000 9,900,000
Long-term Liabilities 0 0 0
Net Assets 7,320,000 7,320,000 9,900,000
Share Capital & Reserves
Share Cap 1,006,000 1,006,000 998,000
Profit & Loss Reserves -7,208,000 -7,208,000 -4,344,000
Other Reserves 13,522,000 13,522,000 13,246,000
Shareholders Funds 7,320,000 7,320,000 9,900,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2017 31-Dec-2014 31-Dec-2013
Tangible Fixed Assets - - -
Fixed Assets 0.6% 0.6% 0.5%
Stocks Inventory 0.3% 0.3% 0.2%
Debtors 2.8% 2.8% 1.1%
Cash Bank In Hand 88.1% 88.1% 96.8%
Current Assets 99.4% 99.4% 99.5%
Creditors Due Within One Year 3.8% 3.8% 3.6%
Net Current Assets Liabilities 95.5% 95.5% 95.9%
Creditors Due After One Year 0.0% 0.0% 0.0%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 96.2% 96.2% 96.4%
Called Up Share Capital 13.2% 13.2% 9.7%
Share Capital Allotted Called Up Paid 13.2% 13.2% 9.7%
Profit Loss Account Reserve -94.7% -94.7% -42.3%
Shareholder Funds 96.2% 96.2% 96.4%
Capital Employed - - -
Total Assets Less Current Liabilities 96.2% 96.2% 96.4%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2017 31-Dec-2014 31-Dec-2013
Liquidity Ratio 25.9 25.9 27.6
Solvency Ratio 26.1 26.1 27.8
Reserves to Assets -0.9 -0.9 -0.4
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2017 31-Dec-2014 31-Dec-2013
Assets 7,612,000 7,612,000 10,270,000
Debt 292,000 292,000 370,000
Net Assets/Debt 7,320,000 7,320,000 9,900,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around NW1 0NH
CONVENTION ASSOCIATES LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR DIAGNOSTICS LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR SERVICES LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR THERAPEUTICS LIMITED
The London Bioscience Innovation Centre, 2 Royal College Street, London, NW1 0NH
IQUR LIMITED
THE LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
LEUCID BIO LTD
BUILDING 1000 BEACH DRIVE, WATERBEACH, CAMBRIDGE, NW1 0NH
BIO2BUSINESS LIMITED
London Bioscience Innovation Centre 2, Royal College Street, London, NW1 0NH
BUGS BIOSCIENCE LIMITED
2 ROYAL COLLEGE STREET, LONDON BIOSCIENCE INNOVATION CENTRE, LONDON, NW1 0NH
DELTADOT LIMITED
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
NANOREGMED LTD
LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
Document Filings
Final Gazette dissolved following liquidation
Return of final meeting in a Members' voluntary winding up
Registered office address changed from 2 Royal College Street London NW1 0NH England to Rsm Restructuring Advisory Llp Central Square 5th Floor 29 Wellington Street Leeds LS1 4DL on 1 June 2018
Declaration of solvency
Appointment of a voluntary liquidator
Resolutions
Memorandum and Articles of Association
Termination of appointment of James Nicholas Gerald White as a director on 23 December 2017
Termination of appointment of James Nicholas Gerald White as a director on 23 December 2017
Termination of appointment of Karl Robertson Van Horn as a director on 23 December 2017
Termination of appointment of Marcelo Leonardo Bravo as a director on 23 December 2017
Resolutions
Resolutions
Change of name notice
Statement of capital on 19 December 2017
Certificate of reduction of issued capital and share premium and cancellation of share premium
Reduction of iss capital and minute (oc)
Sub-division of shares on 27 November 2017
Change of share class name or designation
Confirmation statement made on 7 October 2017 with no updates
Notification of Woodford Investment Management as a person with significant control on 6 April 2016
Confirmation statement made on 7 October 2016 with updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2024 Check Free